Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer. (December 2016) - Ylstra, B.; Cordes, M.; Biesma, H.D.; Verheul, H.M.; Neerincx, M.; Koopman, M.; Punt, C.J.; Meijer, G.A.; Murphy, V.; Barat, A.; Betge, J.; Ebert, M.; et al.